Amer Renal Assoc Top Management
Amer Renal employs about 5 K people. The company is managed by 12 executives with a total tenure of roughly 96 years, averaging almost 8.0 years of service per executive, having 414.75 employees per reported executive. Analysis of Amer Renal's management performance can provide insight into the company performance.
| Joseph Carlucci Chairman Chairman of the Board, Chief Executive Officer, Co-Founder |
| Syed Kamal President President, Co-Founder, Director |
Amer |
Amer Renal Management Team Effectiveness
The company has Return on Asset of 4.35 % which means that on every $100 spent on assets, it made $4.35 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 17.51 %, implying that it generated $17.51 on every 100 dollars invested. Amer Renal's management efficiency ratios could be used to measure how well Amer Renal manages its routine affairs as well as how well it operates its assets and liabilities.Amer Renal Workforce Comparison
Amer Renal Assoc is number one stock in number of employees category among its peers. The total workforce of Diagnostics & Research industry is presently estimated at about 28,899. Amer Renal retains roughly 4,977 in number of employees claiming about 17% of equities under Diagnostics & Research industry.
The company has Net Profit Margin of (1.11) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 9.73 %, which entails that for every 100 dollars of revenue, it generated $9.73 of operating income. Amer Renal Notable Stakeholders
An Amer Renal stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Amer Renal often face trade-offs trying to please all of them. Amer Renal's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Amer Renal's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Joseph Carlucci | Chairman of the Board, Chief Executive Officer, Co-Founder | Profile | |
| Syed Kamal | President, Co-Founder, Director | Profile | |
| Don Williamson | Chief Operating Officer, Executive Vice President | Profile | |
| Mark Herbers | Interim Chief Financial Officer, Interim Chief Accounting Officer | Profile | |
| Thomas Erickson | Independent Director | Profile | |
| Jared Hendricks | Independent Director | Profile | |
| John Jureller | Independent Director | Profile | |
| Robert Fish | Independent Director | Profile | |
| Michael Boxer | Independent Director | Profile | |
| Susanne Clark | Independent Director | Profile | |
| Jeremy Gelber | Independent Director | Profile | |
| Christopher Hocevar | Independent Director | Profile |
Amer Renal Workforce Analysis
Traditionally, organizations such as Amer Renal use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Amer Renal within its industry.Amer Renal Manpower Efficiency
Return on Amer Renal Manpower
| Revenue Per Employee | 163.6K | |
| Revenue Per Executive | 67.8M | |
| Net Loss Per Employee | 3.4K | |
| Net Loss Per Executive | 1.4M | |
| Working Capital Per Employee | 19.3K | |
| Working Capital Per Executive | 8M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Amer Stock
If you are still planning to invest in Amer Renal Assoc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Renal's history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |